NPRL2 Polyclonal Antibody, 20ul Monoclonal Antibody Preparation translocates into the nucleus

translocates into the nucleus

suggesting its involvement in the TP53-dependent regulatory pathway

Experience the power of LightNing™ StuI Restriction Enzymes

tube1:3/8"x5/8"TPE tube 50cm

The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum

NPRL2 Polyclonal Antibody, 20ul Monoclonal Antibody Preparation translocates into the nucleusSuppresses Src dependent tyrosine phosphorylation and activation of PDPK1 and its downstream signaling. Down regulates PDPK1 kinase activity by interfering with tyrosine phosphorylation at the Tyr 9 Tyr 373 and Tyr 376 residues. May act as a tumor suppressor. Suppresses cell growth and enhanced sensitivity to various anticancer drugs.